Home Healthcare Healthcare Services Antibody Optimization Services Market

Antibody Optimization Services Market Size, Share & Trends Analysis Report By Type (Affinity maturation, Humanization, Fc engineering, Stability optimization, Others), By Technology (Phage display, Yeast/mammalian display, Ribosome/mRNA display, AI-based computational optimization), By Application (Oncology, Autoimmune & inflammatory diseases, Infectious diseases, Neurological disorders, Others), By End Use (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 16, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Antibody Optimization Services Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Affinity maturation
    2. Humanization
    3. Fc engineering
    4. Stability optimization
    5. Others
  2. Antibody Optimization Services Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Phage display
    2. Yeast/mammalian display
    3. Ribosome/mRNA display
    4. AI-based computational optimization
  3. Antibody Optimization Services Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Autoimmune & inflammatory diseases
    3. Infectious diseases
    4. Neurological disorders
    5. Others
  4. Antibody Optimization Services Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical Companies
    2. Biotechnology Companies
    3. Contract Research Organizations (CROs)
    4. Academic & Research Institutes
  5. Regional Antibody Optimization Services Market
    1. North America
      1. North America Antibody Optimization Services Market By Type 2022-2034 (USD MILLION/ Units)
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
      2. North America Antibody Optimization Services Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Phage display
        2. Yeast/mammalian display
        3. Ribosome/mRNA display
        4. AI-based computational optimization
      3. North America Antibody Optimization Services Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune & inflammatory diseases
        3. Infectious diseases
        4. Neurological disorders
        5. Others
      4. North America Antibody Optimization Services Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Academic & Research Institutes
      5. U.S.
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      6. Canada
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
    2. Europe
      1. Europe Antibody Optimization Services Market By Type 2022-2034 (USD MILLION/ Units)
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
      2. Europe Antibody Optimization Services Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Phage display
        2. Yeast/mammalian display
        3. Ribosome/mRNA display
        4. AI-based computational optimization
      3. Europe Antibody Optimization Services Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune & inflammatory diseases
        3. Infectious diseases
        4. Neurological disorders
        5. Others
      4. Europe Antibody Optimization Services Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Academic & Research Institutes
      5. U.K.
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      6. Germany
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      7. France
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      8. Spain
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      9. Italy
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      10. Russia
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      11. Nordic
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      12. Benelux
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      13. Rest of Europe
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
    3. APAC
      1. APAC Antibody Optimization Services Market By Type 2022-2034 (USD MILLION/ Units)
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
      2. APAC Antibody Optimization Services Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Phage display
        2. Yeast/mammalian display
        3. Ribosome/mRNA display
        4. AI-based computational optimization
      3. APAC Antibody Optimization Services Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune & inflammatory diseases
        3. Infectious diseases
        4. Neurological disorders
        5. Others
      4. APAC Antibody Optimization Services Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Academic & Research Institutes
      5. China
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      6. Korea
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      7. Japan
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      8. India
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      9. Australia
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      10. Taiwan
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      11. South East Asia
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      12. Rest of Asia-Pacific
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Antibody Optimization Services Market By Type 2022-2034 (USD MILLION/ Units)
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
      2. Middle East and Africa Antibody Optimization Services Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Phage display
        2. Yeast/mammalian display
        3. Ribosome/mRNA display
        4. AI-based computational optimization
      3. Middle East and Africa Antibody Optimization Services Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune & inflammatory diseases
        3. Infectious diseases
        4. Neurological disorders
        5. Others
      4. Middle East and Africa Antibody Optimization Services Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Academic & Research Institutes
      5. UAE
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      6. Turkey
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      7. Saudi Arabia
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      8. South Africa
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      9. Egypt
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      10. Nigeria
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      11. Rest of MEA
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
    5. LATAM
      1. LATAM Antibody Optimization Services Market By Type 2022-2034 (USD MILLION/ Units)
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
      2. LATAM Antibody Optimization Services Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Phage display
        2. Yeast/mammalian display
        3. Ribosome/mRNA display
        4. AI-based computational optimization
      3. LATAM Antibody Optimization Services Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune & inflammatory diseases
        3. Infectious diseases
        4. Neurological disorders
        5. Others
      4. LATAM Antibody Optimization Services Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Academic & Research Institutes
      5. Brazil
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      6. Mexico
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      7. Argentina
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      8. Chile
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      9. Colombia
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
      10. Rest of LATAM
        1. Affinity maturation
        2. Humanization
        3. Fc engineering
        4. Stability optimization
        5. Others
        6. Phage display
        7. Yeast/mammalian display
        8. Ribosome/mRNA display
        9. AI-based computational optimization
        10. Oncology
        11. Autoimmune & inflammatory diseases
        12. Infectious diseases
        13. Neurological disorders
        14. Others
        15. Pharmaceutical Companies
        16. Biotechnology Companies
        17. Contract Research Organizations (CROs)
        18. Academic & Research Institutes
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.